ストックスクリーナーアプリを入手
14.64
3.90%
0.55
アフターアワーズ：
14.53
-0.11
-0.75%
前日終値:
$14.09
開ける：
$15.34
24時間の取引高:
170.98K
Relative Volume:
1.85
時価総額：
$401.06M
収益：
-
当期純損益:
$-102.09M
株価収益率:
-13.94
EPS:
-1.05
ネットキャッシュフロー:
$-108.72M
1週間 パフォーマンス:
-5.00%
1か月 パフォーマンス:
+46.40%
6か月 パフォーマンス:
+62.49%
1年 パフォーマンス:
+276.16%
1日の値動き範囲:
$14.00
$15.97
1週間の範囲:
$13.88
$16.95
52週間の値動き範囲:
$2.2045
$18.00
Dbv Technologies Adr Stock (DBVT) Company Profile
名前
Dbv Technologies Adr
セクター
電話
33(0)155427878
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
DBVT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DBVT
Dbv Technologies Adr
|
14.64 | 476.11M | 0 | -102.09M | -108.72M | -1.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-29 | 再開されました | Goldman | Sell |
| 2023-01-04 | アップグレード | Societe Generale | Hold → Buy |
| 2022-12-16 | ダウングレード | Goldman | Neutral → Sell |
| 2022-05-10 | ダウングレード | Goldman | Buy → Neutral |
| 2021-09-14 | アップグレード | Societe Generale | Hold → Buy |
| 2021-01-22 | ダウングレード | Societe Generale | Hold → Sell |
| 2020-11-02 | アップグレード | Societe Generale | Sell → Hold |
| 2020-08-06 | ダウングレード | Societe Generale | Buy → Sell |
| 2020-08-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-17 | ダウングレード | Stifel | Buy → Hold |
| 2020-01-09 | アップグレード | Stifel | Hold → Buy |
| 2019-12-16 | 開始されました | Citigroup | Buy |
| 2019-09-05 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-06-17 | 開始されました | Goldman | Buy |
| 2018-12-20 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2018-12-20 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2018-12-20 | ダウングレード | Jefferies | Buy → Hold |
| 2018-12-20 | ダウングレード | Stifel | Buy → Hold |
| 2017-10-31 | アップグレード | Societe Generale | Sell → Hold |
| 2017-10-24 | ダウングレード | Societe Generale | Buy → Sell |
| 2017-10-23 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2017-06-23 | 開始されました | Deutsche Bank | Buy |
| 2017-03-16 | アップグレード | Societe Generale | Hold → Buy |
| 2016-09-26 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-03 | 開始されました | Barclays | Overweight |
| 2015-10-23 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Dbv Technologies Adr (DBVT) 最新ニュース
European ADRs Show Mixed Moves In Active Sectors - Finimize
DBV Technologies Reports Q3 2025 Financial Results - MSN
DBV Technologies Appoints Dr. Philina Lee to Board - TipRanks
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors - The Manila Times
DBV Technologies (NASDAQ: DBVT) appoints Philina Lee to Board as independent director - Stock Titan
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting - The Manila Times
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq - markets.businessinsider.com
European ADRs Mostly Flat As Gains And Losses Trade Off - Finimize
DBV Technologies Announces Sale of approximately $30 - GlobeNewswire
DBV Technologies (NASDAQ: DBVT) sells ~$30M in ADSs; dilution ~5.96% - Stock Titan
Health Care And Telecom Drive European ADR Gains In The US - Finimize
Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
DBV Technologies Reports Third Quarter 2025 Financial Results - TradingView
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Optimistic Outlook for DBV Technologies Amid Promising Viaskin Peanut Advancements - TipRanks
Healthcare And Biotech Led European ADRs As Markets Steadied - Finimize
European ADRs Edge Higher As Healthcare Leads Gains - Finimize
Strength Seen in DBV Technologies (DBVT): Can Its 6.8% Jump Turn into More Strength? - Yahoo Finance
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday - Benzinga
Pre-Market Movers: MIRA, ADAP, GNPX Swing Big - RTTNews
Orion, Nio, Alibaba Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Pre-market Movers: GNPX, BFRI, DBVT See Big Swings - RTTNews
DBV Technologies S.A. (NASDAQ:DBVT) Receives $14.75 Consensus Target Price from Brokerages - Defense World
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving PremarketAehr Test System (NASDAQ:AEHR), Amkor Tech (NASDAQ:AMKR) - Benzinga
DBV Technologies raises $30 million through ADS sale on Nasdaq - Investing.com
$30M ADS Sale: DBV Technologies Issues 2,307,692 ADSs via ATM Program on Nasdaq and Euronext Paris - Stock Titan
Biotech Stocks Lead European ADRs Higher On Wall Street - Finimize
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
Morning Market Movers: DBVT, CLPT, DWTX, Seeing Big Swings - RTTNews
DBV Technologies Announces Board Member Resignation - MSN
European Pharma And Biotech Companies Led ADR Gains In The US - Finimize
European ADRs In The US See Modest Gains On Health And Tech - Finimize
What drives DBV Technologies SA DBV stock priceLarge Cap Stability Picks & Use Smart Algorithms to Pick Better Stocks - earlytimes.in
Can DBV Technologies S.A. Depositary Receipt stock reach $100 price target2025 Market Trends & Expert Curated Trade Ideas - newser.com
DBV Technologies Announces Resignation of Board Member - GlobeNewswire
Biotech Board Shake-up: DBV Technologies Director Exits Amid VIASKIN Peanut Patch Development - Stock Titan
DBV Technologies’ SWOT analysis: peanut allergy treatment stock faces pivotal trial - Investing.com
DBV Technologies stock rating reiterated at Market Outperform by JMP - Investing.com
Brokerages Set DBV Technologies S.A. (NASDAQ:DBVT) Target Price at $14.75 - Defense World
Analysts Set DBV Technologies S.A. (NASDAQ:DBVT) Price Target at $14.75 - Defense World
DBV Technologies Establishes an At-The-Market Program on Nasdaq - MarketScreener
DBV Technologies Launches $150M ATM Equity Offering - The Globe and Mail
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq - Placera.se
Dbv Technologies Adr (DBVT) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):